$VREX

Varex Imaging Corporation revenues hit USD 211M in Q3FY26

Varex Imaging reported unaudited Q3 FY2026 results: revenue of $211 million, GAAP gross margin 36% (non-GAAP 37%), GAAP operating margin 11% (non-GAAP 12%), and GAAP diluted EPS $0.37 (non-GAAP $0.31). Third-quarter revenues rose 4% YoY, with Medical $134 million and Industrial $77 million. The company received $17 million in U.S. Customs refunds tied to IEEPA tariffs.

Original reporting
Published Aug 12, 2026, 10:36 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 6:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$VREX
Bullish
medium confidence
Mentioned
$VREX
Relevance
7/10
alphai data visualization · based on medicalbuyer.co.in
Decision brief

The 30-second read

$VREXBullishMed
01

Why it matters

Traders may re-rate near-term earnings quality by separating core product sales growth from tariff reimbursement effects, while monitoring whether margin expansion persists into Q4.

02

Market read

A company-specific earnings release with detailed margin, EPS, cash flow, and tariff adjustment disclosures that can drive positioning into Q4.

03

What to watch

Cash fell to $99M from $155M at FY25, and the article does not quantify how much of the gross profit improvement is recurring versus adjustment-driven.

Relevance 7/10Novelty 6/10Timing: reported Q3FY26 results, entering the fourth quarter with “continued momentum”

Background

Varex Imaging released unaudited Q3FY26 results and discussed IEEPA-related customer reimbursement adjustments and US Customs refunds.

Company-level read

Ticker impact

$VREXBullishMedium confidence
Context

Varex reported unaudited Q3FY26 revenue of $211M, with non-GAAP gross margin rising to 37% and operating cash flow of $21M.

Expected impact

Near-term bias modestly positive, with traders likely focusing on sustainability of margin gains and the net effect of IEEPA-related adjustments.

Evidence & confidence

The article provides concrete quarterly financials and explains tariff refunds and revenue reductions, which can affect comparability and forward expectations.

Market effects

Signals demand resilience in industrial and cargo/vehicle inspection systems, potentially supportive for imaging and inspection equipment peers.

IEEPA tariff reimbursement dynamics are US-specific, which may keep attention on US customs and trade-policy impacts for defense-adjacent suppliers.

Tariff and reimbursement mechanics can influence cross-border supply chains and customer reimbursement timing for global inspection systems.

Counterpoint

The revenue and margin picture may be partly driven by one-time tariff reimbursement/refund timing rather than underlying demand strength.

Key entities

  • Varex Imaging Corporation

    Reported Q3FY26 unaudited financial results including $211M revenue, margin expansion, and $21M operating cash flow, plus IEEPA tariff refund/reimbursement adjustments.

  • Sunny Sanyal

    CEO quoted on product sales growth, tariff recovery, and momentum into Q4.

Related articles

$TDYHighAI 9/10

Los Angeles Business Journal

Teledyne Technologies (TDY) agreed to acquire Varex Imaging (VREX) for $1.1B, or $18.90 per share in cash. The deal is expected to close in 2027. Varex's X-ray imaging tech complements Teledyne's portfolio, according to Varex's CEO. Teledyne has previously acquired firms in the healthcare sector, including Dalsa Corp. and DD-Scientific.

$TDYMedAI 9/10

Why Is Teledyne Technologies (TDY) Paying a 52% Premium for Varex (VREX)?

Teledyne Technologies (NYSE:TDY) agreed to acquire Varex Imaging (NASDAQ:VREX) for $18.90 per share in cash, a 52% premium to Varex’s unaffected close. The deal values Varex at about $1.1 billion including equity awards and net debt. Varex jumped 48.5% to $18.42 on Aug. 10; TDY fell slightly. Teledyne cited synergies but did not quantify EPS accretion.

$TDYMedAI 9/10

Teledyne Technologies to Acquire Varex Imaging

Teledyne Technologies agreed to acquire all outstanding shares of Varex Imaging under a definitive deal approved unanimously by both boards. Varex makes X-ray sources and digital detectors plus imaging software for medical and industrial inspection. The deal is expected to close in early 2027, pending regulatory and Varex stockholder approval.